Management of diabetic retinopathy: a systematic review.

PubWeight™: 3.47‹?› | Rank: Top 1%

🔗 View Article (PMID 17712074)

Published in JAMA on August 22, 2007

Authors

Quresh Mohamed1, Mark C Gillies, Tien Y Wong

Author Affiliations

1: Centre for Eye Research Australia, University of Melbourne and Royal Victorian Eye and Ear Hospital, Melbourne, Australia.

Articles citing this

(truncated to the top 100)

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. N Engl J Med (2017) 2.56

Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev (2015) 2.19

Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care (2009) 1.55

Abnormal angiogenesis in diabetic nephropathy. Diabetes (2009) 1.53

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes (2010) 1.53

Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study. BMJ (2015) 1.45

Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech (2012) 1.38

Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care (2008) 1.35

Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol (2009) 1.34

Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care (2008) 1.33

The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin (2009) 1.30

Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci (2011) 1.26

Resource use and costs associated with diabetic macular edema in elderly persons. Arch Ophthalmol (2008) 1.25

Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care (2009) 1.25

The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23

Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics (2008) 1.23

Endoplasmic reticulum stress and diabetic retinopathy. Vasc Health Risk Manag (2008) 1.21

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review. BMJ (2012) 1.17

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) (2015) 1.14

Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol (2011) 1.12

Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr (2009) 1.08

Advances in the medical treatment of diabetic retinopathy. Diabetes Care (2009) 1.06

Stem cell therapy for retinal diseases: update. Stem Cell Res Ther (2011) 1.05

Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care (2009) 1.04

Construction of an inexpensive, hand-held fundus camera through modification of a consumer "point-and-shoot" camera. Invest Ophthalmol Vis Sci (2012) 1.02

Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases. Curr Drug Targets (2013) 1.01

High calorie diet triggers hypothalamic angiopathy. Mol Metab (2012) 1.01

High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. Diabetes (2010) 1.00

Retracted Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics (2007) 1.00

A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One (2012) 0.97

Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats. Diabetes (2011) 0.96

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies. Eye (Lond) (2011) 0.96

Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics. Ophthalmology (2012) 0.95

Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci (2014) 0.95

Vascular complications and diabetes: current therapies and future challenges. J Ophthalmol (2012) 0.95

Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol (2013) 0.94

Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health (2014) 0.93

Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease? Invest Ophthalmol Vis Sci (2011) 0.93

Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol (2015) 0.91

Human genetics of diabetic retinopathy: current perspectives. J Ophthalmol (2010) 0.91

Structural changes in individual retinal layers in diabetic macular edema. J Diabetes Res (2013) 0.91

Renal endothelial dysfunction in diabetic nephropathy. Cardiovasc Hematol Disord Drug Targets (2014) 0.90

Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest (2008) 0.89

Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int (2014) 0.89

Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy. Can J Ophthalmol (2013) 0.89

Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm (2012) 0.89

Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5. Br J Pharmacol (2008) 0.87

Plasma kallikrein-kinin system and diabetic retinopathy. Biol Chem (2013) 0.87

PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies. PPAR Res (2008) 0.86

Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus. Mol Vis (2013) 0.86

Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials. Diabetes Care (2011) 0.86

Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health (2013) 0.86

Microvascular disease in children and adolescents with type 1 diabetes and obesity. Pediatr Nephrol (2010) 0.85

Five-year visual outcome following laser photocoagulation of diabetic macular oedema. Eye (Lond) (2011) 0.85

Analysis of foveal avascular zone for grading of diabetic retinopathy severity based on curvelet transform. Graefes Arch Clin Exp Ophthalmol (2012) 0.85

Dyslipidemia and diabetic retinopathy. Rev Diabet Stud (2013) 0.84

Diabetic retinopathy grading by digital curvelet transform. Comput Math Methods Med (2012) 0.84

Steroid-induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol (2012) 0.84

Risk factors for diabetic retinopathy: a case-control study. Int J Retina Vitreous (2016) 0.83

Candidate gene association study for diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis (2014) 0.83

Unintended consequences of delisting routine eye exams on retinopathy screening for people with diabetes in Ontario, Canada. CMAJ (2013) 0.83

Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy. Int J Ophthalmol (2013) 0.82

Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema. Oman J Ophthalmol (2009) 0.82

Diabetic Retinopathy Screening and Monitoring of Early Stage Disease in Australian General Practice: Tackling Preventable Blindness within a Chronic Care Model. J Diabetes Res (2015) 0.82

The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes. J Diabetes Complications (2014) 0.82

MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy. Eye (Lond) (2014) 0.82

Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis. Angiogenesis (2013) 0.82

Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ. Invest Ophthalmol Vis Sci (2014) 0.82

Protective effects of Morus alba leaves extract on ocular functions of pups from diabetic and hypercholesterolemic mother rats. Int J Biol Sci (2011) 0.82

No loss of chance of diabetic retinopathy screening by endocrinologists with a digital fundus camera. Diabetes Care (2011) 0.82

Rodent Hyperglycemia-Induced Inner Retinal Deficits are Mirrored in Human Diabetes. Transl Vis Sci Technol (2014) 0.81

Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes. Diabetologia (2015) 0.81

Suitability of a Low-Cost, Handheld, Nonmydriatic Retinograph for Diabetic Retinopathy Diagnosis. Transl Vis Sci Technol (2016) 0.81

The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy. BMC Ophthalmol (2012) 0.81

The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells. Invest Ophthalmol Vis Sci (2011) 0.80

Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord (2014) 0.80

Systemic medical management of diabetic retinopathy. Middle East Afr J Ophthalmol (2013) 0.80

Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy. Int J Ophthalmol (2013) 0.80

Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. BMC Med Inform Decis Mak (2013) 0.80

Erythropoetin receptor expression in the human diabetic retina. BMC Res Notes (2009) 0.80

Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLoS One (2014) 0.80

Retrobulbar blood flow changes in eyes with diabetic retinopathy: a 10-year follow-up study. Clin Ophthalmol (2014) 0.79

Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy. Jpn J Ophthalmol (2015) 0.79

Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV). PLoS One (2015) 0.79

Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis. Syst Rev (2015) 0.79

Anorexia nervosa - medical complications. J Eat Disord (2015) 0.79

Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats. BMC Complement Altern Med (2015) 0.79

Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy. Invest Ophthalmol Vis Sci (2016) 0.78

[Vitamins for the eyes? Risks and opportunities for physician and patient]. Ophthalmologe (2009) 0.78

Relationship between Altered Platelet Morphological Parameters and Retinopathy in Patients with Type 2 Diabetes Mellitus. J Ophthalmol (2016) 0.78

Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey. Osteoporos Int (2016) 0.78

An Innovative Australian Outreach Model of Diabetic Retinopathy Screening in Remote Communities. J Diabetes Res (2015) 0.78

Molecular Implications of the PPARs in the Diabetic Eye. PPAR Res (2013) 0.78

Retinal Imaging Techniques for Diabetic Retinopathy Screening. J Diabetes Sci Technol (2016) 0.77

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology. J Diabetes Res (2016) 0.77

Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol (2015) 0.77

Diabetes and obesity: a challenge for every ophthalmologist. Arch Ophthalmol (2009) 0.77

Fluorescein angiography, optical coherence tomography, and histopathologic findings in a VEGF(165) animal model of retinal angiogenesis. Graefes Arch Clin Exp Ophthalmol (2012) 0.76

Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy. CMAJ (2016) 0.76

Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema. Eye (Lond) (2015) 0.76

Articles by these authors

(truncated to the top 100)

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation (2007) 4.97

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer. Nat Med (2012) 4.90

Age-related macular degeneration. Lancet (2012) 4.17

Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology (2010) 3.08

Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83

Macular and nerve fiber layer thickness in amblyopia: the Sydney Childhood Eye Study. Ophthalmology (2009) 2.64

Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med (2008) 2.35

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32

Obesity and eye diseases. Surv Ophthalmol (2007) 2.13

Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care (2008) 2.09

Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08

Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (2007) 2.07

The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol (2004) 2.03

Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol (2009) 2.01

The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology (2010) 1.97

Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care (2010) 1.95

Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol (2009) 1.94

Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology (2010) 1.92

Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91

Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens (2011) 1.89

Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol (2006) 1.89

Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. J Hypertens (2009) 1.89

Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol (2008) 1.85

Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology (2006) 1.83

Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension (2007) 1.83

Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res (2009) 1.81

Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke (2005) 1.78

Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology (2009) 1.76

Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol (2008) 1.75

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology (2004) 1.74

Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res (2007) 1.74

Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension (2006) 1.74

Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain (2010) 1.73

Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. Ophthalmology (2010) 1.73

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology (2002) 1.73

Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology (2006) 1.72

Glycemic index, retinal vascular caliber, and stroke mortality. Stroke (2008) 1.70

Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay eye study (SiMES). Ophthalmic Epidemiol (2007) 1.68

Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study. Ophthalmology (2005) 1.66

Relationship between retinal arteriolar narrowing and myocardial perfusion: multi-ethnic study of atherosclerosis. Hypertension (2007) 1.66

Methodology of the Singapore Indian Chinese Cohort (SICC) eye study: quantifying ethnic variations in the epidemiology of eye diseases in Asians. Ophthalmic Epidemiol (2009) 1.64

Long-term effects of smoking on retinal microvascular caliber. Am J Epidemiol (2007) 1.63

Evidence of arteriolar narrowing in low-birth-weight children. Circulation (2008) 1.62

Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol (2009) 1.60

Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging (2008) 1.60

Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care (2007) 1.59

Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA). PLoS Med (2010) 1.59

Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet (2010) 1.57

Is diabetic retinopathy related to subclinical cardiovascular disease? Ophthalmology (2010) 1.56

Retinal signs and stroke: revisiting the link between the eye and brain. Stroke (2008) 1.54

Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med (2009) 1.54

Relationships between age, blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci (2003) 1.53

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes (2010) 1.53

Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry (2013) 1.53

Collagen-related genes influence the glaucoma risk factor, central corneal thickness. Hum Mol Genet (2010) 1.52

The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol (2002) 1.51

Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology (2008) 1.51

Bevacizumab in ophthalmology: the controversy moves forward. Clin Experiment Ophthalmol (2010) 1.51

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol (2014) 1.51

Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes. Acta Ophthalmol (2015) 1.51

The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2006) 1.51

Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis (2005) 1.50

Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet (2013) 1.49

Changes in refraction over 10 years in an adult population: the Beaver Dam Eye study. Invest Ophthalmol Vis Sci (2002) 1.49

Anti-vascular endothelial growth factor treatment for eye diseases. BMJ (2012) 1.48

Effect of birth parameters on retinal vascular caliber: the Twins Eye Study in Tasmania. Hypertension (2009) 1.46

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ (2007) 1.46

Hypertensive retinopathy and risk of stroke. Hypertension (2013) 1.45

Macular telangiectasia type 2. Prog Retin Eye Res (2012) 1.44

Relationship of retinal vascular caliber with optic disc and macular structure. Am J Ophthalmol (2009) 1.41

Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care (2008) 1.41

Retinal vascular fractal and blood pressure in a multiethnic population. J Hypertens (2013) 1.39

Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes (2008) 1.39

Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech (2012) 1.38

Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet (2013) 1.38

Hydroxychloroquine retinopathy: screening needed to prevent blindness. Med J Aust (2010) 1.38

Conditional Müllercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci (2012) 1.35

Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res (2008) 1.33

Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet (2012) 1.33

Retinal arteriolar narrowing increases the likelihood of chronic kidney disease in hypertension. J Hypertens (2009) 1.30

The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin (2009) 1.30

Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol (2005) 1.30

Determinants of quantitative optic nerve measurements using spectral domain optical coherence tomography in a population-based sample of non-glaucomatous subjects. Invest Ophthalmol Vis Sci (2011) 1.29

Determinants of retinal venular diameter: the Beaver Dam Eye Study. Ophthalmology (2012) 1.29

Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke (2006) 1.28

Prevalence and causes of visual impairment and blindness in an urban Indian population: the Singapore Indian Eye Study. Ophthalmology (2011) 1.27

Diabetes, metabolic abnormalities, and glaucoma. Arch Ophthalmol (2009) 1.27

Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes (2007) 1.26

Determinants of ganglion cell-inner plexiform layer thickness measured by high-definition optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.26

Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care (2009) 1.25

Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Arch Ophthalmol (2008) 1.25

The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project. Invest Ophthalmol Vis Sci (2008) 1.25

A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 1.23

Arterial compliance and retinal vascular caliber in cerebrovascular disease. Ann Neurol (2007) 1.22

Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology (2008) 1.22